XETRA:AJ91
DocCheck AG · XETRA · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 13:36 UTC
Last close
n/aEUR
Market data
9.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
15.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
9.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
4.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.10Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
What it pays out is the furthest below its sector's middle: 0.20 against 0.54 on the market's range.
Then and now
lens 3 of 9| Fact | 2016 | 2025 | Change |
|---|---|---|---|
| Sales | 25,936,401 | 55,315,408 | +113% |
| Profit | 2,664,541 | 5,334,223 | +100% |
| Free cash flow | 2,065,785 | 2,613,770 | +26.5% |
| Debt | 36,000 | 4,161,899 | +11,461% |
| Shares in issue | 5,008,401 | 5,073,816 | +1.3% |
The same five facts for 2016 and 2025, each read from the year's own filing.
The same five facts for 2016 and 2025, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2016
Sales, 201625,936,401
- Source
- computed
- Statement
- income
- Fiscal year
- 2016
- Reported in
- EUR
Sales, 202555,315,408Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Profit, 20162,664,541
- Source
- computed
- Statement
- income
- Fiscal year
- 2016
- Reported in
- EUR
Profit, 20255,334,223Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Free cash flow, 20162,065,785
- Source
- computed
- Statement
- income
- Fiscal year
- 2016
- Reported in
- EUR
Free cash flow, 20252,613,770Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Debt, 201636,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2016
- Reported in
- EUR
Debt, 20254,161,899Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Shares in issue, 20165,008,401
- Source
- computed
- Statement
- income
- Fiscal year
- 2016
- Reported in
- EUR
Shares in issue, 20255,073,816Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR